pierre legault  gowling wlg we use cookies on our website to learn more about cookies how we use them on our site and how to change your cookie settings please view our cookie policy by continuing to use this site without changing your settings you consent to our use of cookies in accordance with our cookie policy ok your region is set to  if this is incorrect please change your region skip navigation people peopleinsights  resourcessectors  servicesnewsevents content type people insights  resources sectors  services news events search for canada  people  pierre legault pierre legault partner speaks english french year of call   quebec   pierrelegaultgowlingwlgcom download vcard primary office montréal email pierrelegaultgowlingwlgcom pierre legault pierre legault is a partner in gowling wlgs montréal office he has developed an active practice that focuses primarily on civil commercial administrative and insurance law in this regard he has represented major canadian corporations in matters involving both domestic and international implications in the fields of commercial and contractual litigation business and banking litigation insurance law product liability directors and officers liability oppression remedies and regulatory issues he is also involved in the energy field and has been responsible for various files relating to interconnection agreements electricity transmission cogeneration power purchase and power transmission agreements pierre is presently acting and has been called upon to counsel clients in a number of class action suits involving securities law fiscal regulatory compliance consumer law product liability and professional liability issues he has represented clients before the supreme court of canada and at all court levels in québec as well as before arbitration administrative tribunals and regulatory bodies pierre joined the firm in  show less show all expertise career  recognition view full career  recognition timeline november legal  canada  august the best lawyers in canada  september the best lawyers in canada  september the best lawyers in canada   year of call quebec featured news bestever showing for gowlings in latest guide to the best lawyers in canada august   featured insights  resources memberships career  recognition  november  legal  canada   august  the best lawyers in canada   september  the best lawyers in canada   september  the best lawyers in canada    year of call quebec   university of ottawa llb pierre legault profile highlights pierre legault pierre legault is a partner in gowling wlgs montréal office he has developed a see full profile memberships pierre legault profile highlights pierre legault pierre legault is a partner in gowling wlgs montréal office he has developed a see full profile insights  resources client work pierre legault profile highlights pierre legault pierre legault is a partner in gowling wlgs montréal office he has developed a see full profile find similar people retail  franchising litigation  dispute resolution energy manufacturing oil  gas construction  engineering mining pierre legault  nephrogenex inc search for search twitter google facebook print contact us contact us innovative therapies for kidney disease company about us management team board of directors scientific advisory board kidney disease chronic kidney disease diabetic nephropathy acute kidney injury product candidates oral pyridorin intravenous pyridorin publications  abstracts science mechanism of action clinical trials pipeline pioneer phase  program previous clinical studies pyr pyr pyr company about us management team board of directors scientific advisory board kidney disease chronic kidney disease diabetic nephropathy acute kidney injury product candidates oral pyridorin intravenous pyridorin publications  abstracts science mechanism of action clinical trials pipeline pioneer phase  program previous clinical studies pyr pyr pyr about us management team board of directors scientific advisory board pierre legault director pierre legault is the former chief executive officer of nephrogenex and has been a member of the company’s board of directors since november  mr legault formerly served as ceo of prosidion ltd a midsize uk biotechnology firm mr legault has also served as executive vp chief financial officer and treasurer with osi pharmaceuticals senior executive vp and chief administrative officer of rite aid corporation and president of the eckerd group with overall manager responsibilities for the brooks eckerd operations in the us mr legault also held several senior positions with sanofiaventis and predecessor companies mr legault previously served on the boards of forest laboratories inc and cyclacel pharmaceutical inc he studied at mcgill university university of montreal hec and the harvard business school and holds a six sigma green belt a baa mba ca and cpa diploma armo biosciences appoints pierre legault to board of directors armo biosciences appoints pierre legault to board of directors  mr legault to chair audit committee  news provided by armo biosciences inc apr    et share this article redwood city calif april   prnewswire  armo biosciences inc a latestage immunooncology company today announced the appointment of pierre legault to its board of directors mr legault will serve as chairman of the audit committee pierre is an experienced executive and board member who has extensive knowledge of the biotechnology and pharmaceutical industry and the finance function in both private and publically traded companies said peter van vlasselaer phd president and chief executive officer of armo  we look forward to having pierre lead our audit committee and believe his expertise will complement our board as armo continues to evolve into a laterstage immunooncology company mr legault has over  years of executive leadership experience in the biopharmaceutical industry most recently he served as chief executive officer of nephrogenex from  to  and has served as chairman of the board since  from  to  mr legault was the chief executive officer of prosidion  previously he was the executive vice president chief financial officer and treasurer of osi pharmaceuticals from  to  in addition mr legault was the senior executive vice president and chief administrative officer of rite aid corporation and president of eckerd corporation earlier in his career mr legault worked for sanofiaventis and predecessor companies over a  year period in several leadership positions including president of worldwide dermatology operations and chief financial officer mr legault studied at mcgill university hec montreal and harvard business school he holds an mba baa ca cpa and six sigma green belt diplomas mr legault also serves as a member of the board of directors at poxel syndax and iroko pharmaceuticals about armo biosciencesarmo biosciences is a latestage immunooncology company that is developing a pipeline of novel proprietary products that activate the immune system of cancer patients to recognize and eradicate tumors the companys lead product candidate am stimulates the survival expansion and killing cytotoxic potential of a particular type of white blood cell in the immune system called cd t cells  cd t cells recognize and kill cancer cells and an increased presence of intratumoral cd t cells may result in improved prognosis and survival in patients in addition armo is developing a robust immunooncology pipeline that includes validated product candidates aimed at treating a variety of cancers in combination with standard of care treatments and emerging immunotherapies for more information please visit wwwarmobiocom   to view the original version on pr newswire visithttpwwwprnewswirecomnewsreleasesarmobiosciencesappointspierrelegaulttoboardofdirectorshtml source armo biosciences inc related links httpwwwarmobiocom may    et preview armo biosciences to present at the jefferies  global healthcare conference apr    et preview armo biosciences announces clinical data presentation for immunotherapy am at the th european international kidney cancer symposium my news release contains wide tables view fullscreen also from this source jun    et armo biosciences presents clinical data on immunotherapy am jun    et armo biosciences appoints naiyer a rizvi md to board of explore more news releases in similar topics biotechnology health care  hospitals medical pharmaceuticals personnel announcements you just read armo biosciences appoints pierre legault to board of directors news provided by armo biosciences inc apr    et share this article looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search heartfelt sympathies store  jeanpierre legault plant a tree light a candle donations for questions or help ordering please call  need help with your order   supportheartfeltsympathiescom memorial candle there are some errors in your form one month  one year  forever  enter value  candle from   this field is required the name or signature to be displayed with your online memorial candle message  the message to be displayed with your memorial candle continue to checkout description product details the solitude and quiet peace of a flickering candle has long been a symbol of remembrance the memorial candle program has been designed to help offset the costs associated with hosting this tribute website in perpetuity through the lighting of a memorial candle your thoughtful gesture will be recorded and the proceeds will go directly towards helping ensure that the family and friends of jeanpierre legault can continue to memorialize revisit interact with each other and enhance this tribute for future generations candle will be lit for the limited time of one month candle will be lit for the limited time of one year candle will be lit indefinitely candle message preserved on the memorial site for perpetuity  heartfelt sympathies  terms of use shipping returns privacy policy legault pierre  rue laviolette saintjérôme qc notary public  mapquest legault pierre  rue laviolette saintjérôme qc jyt reviews  6 website menu  reservations make reservations order online tickets tickets see availability nearby directions  sponsored topics payment cash see a problem let us know legal help pierre legault   facebook facebook？english us한국어français francebahasa indonesiapolskiespañolportuguês brasildeutschitalianomessengerfacebook liteinstagramcookie facebook   armo biosciences appoints pierre legault to board of directors employer login post jobs job seeker login sign up search life sciences jobs search job title only radius miles km  news  news by subject  news by disease   news by date  search news get our freeindustry enewsletter email       armo biosciences appoints pierre legault to board of directors tweet   am   life sciences jobs     bullet newest jobs  last  hours   bullet california jobs   bullet massachusetts jobs   bullet new jersey jobs   bullet maryland jobs   bullet washington jobs   view more jobs redwood city calif april   prnewswire  armo biosciences inc a latestage immunooncology company today announced the appointment of pierre legault to its board of directors mr legault will serve as chairman of the audit committeepierre is an experienced executive and board member who has extensive knowledge of the biotechnology and pharmaceutical industry and the finance function in both private and publically traded companies said peter van vlasselaer phd president and chief executive officer of armo  we look forward to having pierre lead our audit committee and believe his expertise will complement our board as armo continues to evolve into a laterstage immunooncology companymr legault has over  years of executive leadership experience in the biopharmaceutical industry most recently he served as chief executive officer of nephrogenex from  to  and has served as chairman of the board since  from  to  mr legault was the chief executive officer of prosidion  previously he was the executive vice president chief financial officer and treasurer of osi pharmaceuticals from  to  in addition mr legault was the senior executive vice president and chief administrative officer of rite aid corporation and president of eckerd corporation earlier in his career mr legault worked for sanofiaventis and predecessor companies over a  year period in several leadership positions including president of worldwide dermatology operations and chief financial officer mr legault studied at mcgill university hec montreal and harvard business school he holds an mba baa ca cpa and six sigma green belt diplomasmr legault also serves as a member of the board of directors at poxel syndax and iroko pharmaceuticalsabout armo biosciencesarmo biosciences is a latestage immunooncology company that is developing a pipeline of novel proprietary products that activate the immune system of cancer patients to recognize and eradicate tumors the companys lead product candidate am stimulates the survival expansion and killing cytotoxic potential of a particular type of white blood cell in the immune system called cd t cells  cd t cells recognize and kill cancer cells and an increased presence of intratumoral cd t cells may result in improved prognosis and survival in patients in addition armo is developing a robust immunooncology pipeline that includes validated product candidates aimed at treating a variety of cancers in combination with standard of care treatments and emerging immunotherapies for more information please visit wwwarmobiocom to view the original version on pr newswire visithttpwwwprnewswirecomnewsreleasesarmobiosciencesappointspierrelegaulttoboardofdirectorshtmlsource armo biosciences inc read at biospacecom related news armo biosciences announces first patient dosed in pivotal phase iii trial of immunotherapy am for advanced pancreatic cancer the billionaire and the drug pricefixing scandal armo biosciences immunotherapy am receives orphan designation in europe for the treatment of pancreatic cancer gilead gilds rumored ma target incyte incy doubled ceos pay package in  armo biosciences announces clinical data presentation for immunotherapy am at the th european international kidney cancer symposium men still hold  out of  life science director positions armo biosciences announces clinical data presentations for immunotherapy am at asco  annual meeting ophthotech opht cofounder and ceo to step down cfo named new leader armo biosciences release company presents new phase ib clinical data for am in advanced pancreatic cancer patients at  gastrointestinal cancers symposium bristolmyers squibb bmy shakes up management cso to leave in june please enable javascript to view the comments powered by disqus comments powered by disqus • biospacecom • armo biosciences   • biotechpharma  personnel                 t   contact français industrial business directory industries granby inc business sector  metallic products company informations sébastien provost yves legault mario bouchard pierre fournier  employees tank accessories skid tanks tanks for petroleum products storage aboveground tanks for oil residential oil furnaces contact the business   wwwgranbyindustriescom  rue andréliné granby qc jj j canada granby and region industrial development  boulevard industrielgranby québec jj e t       f   infogranbyindustrielcom invest in granby find a business contact us version française linfo industrielle subscribe to our newsletterin french only subscribe here t   contact français about usour services mission our services business financing programs our partners team and board of directors industrial park invest ingranby entrepreneuriathauteyamaska services and territory support for entrepreneurs available financing industrialincubator citig welcome to citig admission criteria services and advantages personalised support committee incubated businesses meeting room rental industryprofile profile of industry poles of excellence and regional assets business directory foreign subsidiaries economic statistics granby in numbers a bit of history economics newsnewsletter media zone documents